Report Detail

Other Global Gastric Cancer Drugs Market Size, Status and Forecast 2019-2025

  • RnM3411284
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 pages
  • |
  • QYResearch
  • |
  • Other

Global Gastric Cancer Drugs Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gastric Cancer Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Doxorubicin Hydrochloride
      • 1.4.3 Sunitinib
      • 1.4.4 Docetaxel
      • 1.4.5 Mitomycin
      • 1.4.6 Fluorouracil
      • 1.4.7 Imatinib
      • 1.4.8 Trastuzumab
    • 1.5 Market by Application
      • 1.5.1 Global Gastric Cancer Drugs Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gastric Cancer Drugs Market Size
    • 2.2 Gastric Cancer Drugs Growth Trends by Regions
      • 2.2.1 Gastric Cancer Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Gastric Cancer Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gastric Cancer Drugs Market Size by Manufacturers
      • 3.1.1 Global Gastric Cancer Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gastric Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gastric Cancer Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gastric Cancer Drugs Key Players Head office and Area Served
    • 3.3 Key Players Gastric Cancer Drugs Product/Solution/Service
    • 3.4 Date of Enter into Gastric Cancer Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gastric Cancer Drugs Market Size by Type (2014-2019)
    • 4.2 Global Gastric Cancer Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gastric Cancer Drugs Market Size (2014-2019)
    • 5.2 Gastric Cancer Drugs Key Players in United States
    • 5.3 United States Gastric Cancer Drugs Market Size by Type
    • 5.4 United States Gastric Cancer Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Gastric Cancer Drugs Market Size (2014-2019)
    • 6.2 Gastric Cancer Drugs Key Players in Europe
    • 6.3 Europe Gastric Cancer Drugs Market Size by Type
    • 6.4 Europe Gastric Cancer Drugs Market Size by Application

    7 China

    • 7.1 China Gastric Cancer Drugs Market Size (2014-2019)
    • 7.2 Gastric Cancer Drugs Key Players in China
    • 7.3 China Gastric Cancer Drugs Market Size by Type
    • 7.4 China Gastric Cancer Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Gastric Cancer Drugs Market Size (2014-2019)
    • 8.2 Gastric Cancer Drugs Key Players in Japan
    • 8.3 Japan Gastric Cancer Drugs Market Size by Type
    • 8.4 Japan Gastric Cancer Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gastric Cancer Drugs Market Size (2014-2019)
    • 9.2 Gastric Cancer Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Gastric Cancer Drugs Market Size by Type
    • 9.4 Southeast Asia Gastric Cancer Drugs Market Size by Application

    10 India

    • 10.1 India Gastric Cancer Drugs Market Size (2014-2019)
    • 10.2 Gastric Cancer Drugs Key Players in India
    • 10.3 India Gastric Cancer Drugs Market Size by Type
    • 10.4 India Gastric Cancer Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gastric Cancer Drugs Market Size (2014-2019)
    • 11.2 Gastric Cancer Drugs Key Players in Central & South America
    • 11.3 Central & South America Gastric Cancer Drugs Market Size by Type
    • 11.4 Central & South America Gastric Cancer Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gastric Cancer Drugs Introduction
      • 12.1.4 Sanofi Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 Eli Lilly
      • 12.2.1 Eli Lilly Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gastric Cancer Drugs Introduction
      • 12.2.4 Eli Lilly Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.2.5 Eli Lilly Recent Development
    • 12.3 F. Hoffmann-La Roche
      • 12.3.1 F. Hoffmann-La Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gastric Cancer Drugs Introduction
      • 12.3.4 F. Hoffmann-La Roche Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.3.5 F. Hoffmann-La Roche Recent Development
    • 12.4 Otsuka Pharmaceutical
      • 12.4.1 Otsuka Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gastric Cancer Drugs Introduction
      • 12.4.4 Otsuka Pharmaceutical Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.4.5 Otsuka Pharmaceutical Recent Development
    • 12.5 Novartis
      • 12.5.1 Novartis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gastric Cancer Drugs Introduction
      • 12.5.4 Novartis Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.5.5 Novartis Recent Development
    • 12.6 Amgen
      • 12.6.1 Amgen Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Gastric Cancer Drugs Introduction
      • 12.6.4 Amgen Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.6.5 Amgen Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Gastric Cancer Drugs Introduction
      • 12.7.4 Merck Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.7.5 Merck Recent Development
    • 12.8 AstraZeneca
      • 12.8.1 AstraZeneca Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Gastric Cancer Drugs Introduction
      • 12.8.4 AstraZeneca Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.8.5 AstraZeneca Recent Development
    • 12.9 Boehringer Ingelheim
      • 12.9.1 Boehringer Ingelheim Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Gastric Cancer Drugs Introduction
      • 12.9.4 Boehringer Ingelheim Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.9.5 Boehringer Ingelheim Recent Development
    • 12.10 Daiichi-Sankyo
      • 12.10.1 Daiichi-Sankyo Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Gastric Cancer Drugs Introduction
      • 12.10.4 Daiichi-Sankyo Revenue in Gastric Cancer Drugs Business (2014-2019)
      • 12.10.5 Daiichi-Sankyo Recent Development
    • 12.11 Bayer HealthCare

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Gastric cancer drugs are used to treat malignancies, or cancerous growths.
      The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.
      The world gastric cancer drugs market could be classified into seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab.
      In 2018, the global Gastric Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gastric Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastric Cancer Drugs development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      Eli Lilly
      F. Hoffmann-La Roche
      Otsuka Pharmaceutical
      Novartis
      Amgen
      Merck
      AstraZeneca
      Boehringer Ingelheim
      Daiichi-Sankyo
      Bayer HealthCare

      Market segment by Type, the product can be split into
      Doxorubicin Hydrochloride
      Sunitinib
      Docetaxel
      Mitomycin
      Fluorouracil
      Imatinib
      Trastuzumab

      Market segment by Application, split into
      Hospitals
      Clinics
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gastric Cancer Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Gastric Cancer Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gastric Cancer Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Gastric Cancer Drugs. Industry analysis & Market Report on Gastric Cancer Drugs is a syndicated market report, published as Global Gastric Cancer Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Gastric Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,130.79
      4,696.19
      6,261.58
      3,471.39
      5,207.09
      6,942.78
      421,391.10
      632,086.65
      842,782.20
      267,704.58
      401,556.87
      535,409.16
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report